Merck Gets EU Gardasil Recommendation

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

U.S. Centers for Disease Control and Prevention • International News

Merck Gets EU Gardasil Recommendation

July 31, 2006

On Friday, Merck & Co. announced that the Committee for Medicinal Products for Human Use has recommended that the European Commission approve Merck's HPV vaccine Gardasil for females ages 9-26. If approval is granted, Merck plans to sell Gardasil in Europe through Sanofi Pasteur MSD, its joint venture with Sanofi Pasteur, Sanofi-Aventis SA's vaccine division. The U.S. Food and Drug Administration in June licensed the vaccine for use in females ages 9-26.

Back to other news for July 31, 2006

Search the Newsroom archive

Excerpted from:
Associated Press
07.28.06

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.